Clinical Trial Results: Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and immunogenicity of Tdap vaccinations in plasma donors; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine

Snippet

Sponsor: ABO Holdings, Inc. | Conditions: Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 2 | Status: COMPLETED | Results posted: 2026-07-02